Literature DB >> 22528224

Tamoxifen induces apoptosis of mouse microglia cell line BV-2 cells via both mitochondrial and death receptor pathways.

Zhengwei Li1, Jincao Chen2, Ting Lei1, Huaqiu Zhang3.   

Abstract

Little is known about whether tamoxifen (TAM) can affect resting state microglia apoptosis and about the cellular mechanism that may account for this. To explore this question, we incubated the microglia cell line BV-2 cells with TAM at different concentrations. Cell viability was assessed by the MTT assay, and flow cytometric analysis was performed to detect the cell apoptosis rate. Furthermore, mitochondrial membrane potential (Δψm) was tested by flow cytometry, and Bax, Bcl-2, Fas, and Fas-L expression was detected by Western blot. The results demonstrated that TAM decreased cell viability and induced apoptosis of BV-2 cells in a concentration- and time-dependent manner. In addition, disruption of Δψm was followed by up-regulated expression of pro-apoptotic Bax, Fas and Fas-L, and down-regulated expression of anti-apoptotic Bcl-2. These results indicate that TAM may induce apoptosis of BV-2 cells through both mitochondria- and death receptor-mediated pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528224     DOI: 10.1007/s11596-012-0039-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  33 in total

Review 1.  Mitochondria as the central control point of apoptosis.

Authors:  S Desagher; J C Martinou
Journal:  Trends Cell Biol       Date:  2000-09       Impact factor: 20.808

2.  Apoptosis in Biochemistry and Structural Biology. 3-8 February 2004, Keystone, CO, USA.

Authors:  Jean-Bernard Denault; Kelly Boatright
Journal:  IDrugs       Date:  2004-04

Review 3.  Tamoxifen for breast cancer.

Authors:  A Karn; A K Jha; S Shrestha; B Acharya; S Poudel; R B Bhandari
Journal:  JNMA J Nepal Med Assoc       Date:  2010 Jan-Mar       Impact factor: 0.406

4.  Tamoxifen-induced apoptosis of rat C6 glioma cells via PI3K/Akt, JNK and ERK activation.

Authors:  Ying Feng; Jintao Huang; Ying Ding; Fukang Xie; Xiaoyan Shen
Journal:  Oncol Rep       Date:  2010-12       Impact factor: 3.906

Review 5.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

6.  Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.

Authors:  A Kallio; A Zheng; J Dahllund; K M Heiskanen; P Härkönen
Journal:  Apoptosis       Date:  2005-12       Impact factor: 4.677

7.  Neuroprotective effects of tamoxifen on experimental spinal cord injury in rats.

Authors:  Ozgür Ismailoğlu; Baha Oral; Aşkin Görgülü; Recep Sütçü; Necdet Demir
Journal:  J Clin Neurosci       Date:  2010-07-13       Impact factor: 1.961

8.  Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.

Authors:  Renhua Guo; Zuhu Huang; Yongqian Shu; Shidai Jin; Hongmei Ge
Journal:  Biomed Pharmacother       Date:  2008-10-23       Impact factor: 6.529

Review 9.  Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects.

Authors:  R R Love
Journal:  J Clin Oncol       Date:  1989-06       Impact factor: 44.544

10.  Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

Authors:  N Zamzami; P Marchetti; M Castedo; C Zanin; J L Vayssière; P X Petit; G Kroemer
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.